With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. Nevertheless, at least as far as ...

This deal comes a little after Bayer broke its pharma dealmaking fast and the company looks to optimise its long-term ...

Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal to secure 3 billion ...

Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish pharmaceutical company. Orion believes that long-term annual net sales from Nubeqa, ...

ZURICH, Jan 14 (Reuters) - Bayer (BAYGn.DE), opens new tab will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the German company's ...

Bayer (XTRA:BAYN) is in focus after U.S. farm groups criticized its push for import duties on Chinese glyphosate, at the same ...

The University of Colorado Anschutz, UCHealth and Children's Hospital Colorado are partnering with Bayer on a research ...

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptive ...

Bayer is a German multinational developer and provider of pharmaceutical and agricultural products and services.

Guth is chief operating officer for Bayer Pharmaceuticals and president of Bayer U.S. Whether it’s Vice President Kamala Harris or former President Donald Trump in the White House that day, the health ...

Nelson Ambrogio appointed to lead U.S. pharmaceuticals business, Bayer’s largest pharmaceutical growth market Appointment supports Bayer Pharmaceuticals’ strategy to renew top-line growth and maximize ...